Dr Munir: What Drives Frontline CLL Treatment Decisions Today?ByTalha Munir, MBChB, PhDJune 29th 2026Explore how genomics, comorbidities, and patient goals steer frontline CLL therapy, from fixed-duration venetoclax regimens to continuous BTK inhibitors.